The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Abstract
There is currently no universally accepted numbering convention for the antiviral drug-related resistance mutations in the reverse transcriptase (rt) domain of the human hepatitis B virus (HBV) polymerase. The published inconsistencies have resulted from different HBV genotypes. A standardized numbering system for HBV polymerase is proposed. The new system is based on functional observations of HBV surface gene proteins (preS1, preS2, and HBsAg) and on the current convention used for human immunodeficiency virus type 1 (HIV-1) polymerase proteins (protease, rt, and integrase), in which the amino acid numbering restarts at the first codon position of each domain. The HBV polymerase protein can be divided into 4 domains (terminal protein, spacer, rt, ribonuclease H) and each of these can be numbered separately. In this proposal, the HBV rt domain starts with the highly conserved EDWGPCDEHG motif, contains 344 amino acids, and the lamivudine-related resistance mutations are found at amino acid rtL180M (previously amino acid 528, 526, 515, or 525) and rtM204V/I (previously 552, 550, 539, or 549). The new consensus rt domain numbering system is genotype independent and allows investigators to number any previously and newly discovered antiviral-related amino acid change in a standardized manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Lai, C.-L., Chien, R.-N., Leung, N. W. Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,754
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES
Ules, J., Ienstag, L. D., Chiff, E. U. R. S., Right, L. W., Errillo, R. O. P. P., Ann, L. H., Rowther, L. Y. C., Ondreay, D. C., Oessner, M. A. W., Ubin, M. A. R., et al. (1999) · Cited by 1,116
Vaccine-induced escape mutant of hepatitis B virus
Carman, W. F., Karayiannis, P., Waters, J., Thomas, H. C., Zanetti, A. R., Manzillo, G., & Zuckerman, A. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91874-a · Cited by 1,074
Typing Hepatitis B Virus by Homology in Nucleotide Sequence: Comparison of Surface Antigen Subtypes
Okamoto, H., Tsuda, F., Sakugawa, H., SASTROSOEWIGNJO, R. I., Imai, M., Miyakawa, Y., & Mayumi, M. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-10-2575 · Cited by 1,057
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., & Charnay, P. (1979) · Nature · doi:10.1038/281646a0 · Cited by 981
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Weber, P. C., Lesburg, C. A., Cable, M., Ferrari, E., Hong, Z., & Mannarino, A. F. (1999) · Nature Structural Biology · doi:10.1038/13305 · Cited by 755
Ling, R., Mutimer, D., Ahmed, M., Boxall, E. H., Elias, E., Dusheiko, G. M., & Harrison, T. J. (1996) · Hepatology · doi:10.1002/hep.510240339 · Cited by 466
Benhamou, Y., Bochet, M., Thibault, V., Di Martino, V., Caumes, E., Bricaire, F., Opolon, P., Katlama, C., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510300525 · Cited by 424
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity
Radziwill, G., Tucker, W., & Schaller, H. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.613-620.1990 · Cited by 356
Galibert, F., Chen, T. N., & Mandart, E. (1982) · Journal of Virology · doi:10.1128/jvi.41.1.51-65.1982 · Cited by 284
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase
Zoulim, F., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.6-13.1994 · Cited by 255
Orito, E., Mizokami, M., Ina, Y., Moriyama, E. N., Kameshima, N., Yamamoto, M., & Gojobori, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7059 · Cited by 219
Kahn, J. (1999) · JAMA · doi:10.1001/jama.282.24.2305 · Cited by 199
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription
Weber, M., Bronsema, V, Bartos, H., Bosserhoff, A., Bartenschlager, R., & Schaller, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2994-2999.1994 · Cited by 164
The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.
Bębenek, K., Roberts, J. D., & Kunkel, T. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50565-8 · Cited by 144
Vartanian, J., Meyerhans, A., Sala, M., & Wain–Hobson, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3092 · Cited by 138
Macdonald, D. M., Holmes, E. C., Lewis, J. C. M., & Peter Simmonds, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4253-4257.2000 · Cited by 107
Hepatitis B Virus Replication: Novel Roles for Virus-Host Interactions
Nassal, M. (1999) · Intervirology · doi:10.1159/000024970 · Cited by 103
A new hepadnavirus endemic in arctic ground squirrels in Alaska
Testut, P., Renard, C., Terradillos, O., Vitvitski, L., Tekaia, F., Degott, C., Blake, J., Boyer, B., & Buendia, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4210-4219.1996 · Cited by 100
Fouillot, N., Tlouzeau, S., Rossignol, J., & Jean‐Jean, O. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4886-4895.1993 · Cited by 86
Günther, S., Sommer, G., Plikat, U., Iwanska, A., Wain–Hobson, S., Will, H., & Meyerhans, A. (1997) · Virology · doi:10.1006/viro.1997.8676 · Cited by 86
A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells
Reil, H., Kollmus, H., Weidle, U. H., & Häuser, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5579-5584.1993 · Cited by 63
Lanford, R. E., Kim, Y.-H., Lee, H. H., Notvall, L., & Beames, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1885-1893.1999 · Cited by 52
Hussain, M., & Lok, A. S.-F. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00160.x · Cited by 48
Wei, X., & Peterson, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32617 · Cited by 27
Cited by
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Norder, H., Couroucé, A.-M., Coursaget, P., Echevarria, J. M., Lee, S.-D., Mushahwar, I. K., Robertson, B. H., Locarnini, S., & Magnius, L. O. (2004) · Intervirology · doi:10.1159/000080872 · Cited by 868
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Lok, A. S. F., & McMahon, B. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29401 · Cited by 709
Metadata
- Authors
- Stuyver, L.
- Venue
- Hepatology
- Published
- 2001-03
- Volume
- 33
- Issue
- 3
- Pages
- 751-757
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2142861964
- Cited by
- 382
- References
- 29
- FWCI
- 26.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.